Quantification of myocardial amyloid deposition in tafamidis-treated patients with transthyretin amyloid cardiomyopathy

被引：0
|
作者：
Rettl, R. [1 ]
Wollenweber, T. [1 ]
Mann, C. [1 ]
Duca, F. [1 ]
Dachs, T. -M. [1 ]
Binder, C. [1 ]
Stojanovic, M. [1 ]
Ligios, L. Camuz [1 ]
Schrutka, L. [1 ]
Dalos, D. [1 ]
Charwat-Resl, S. [2 ]
Eslam, R. Badr [1 ]
Kastner, J. [1 ]
Hacker, M. [1 ]
Bonderman, D. [2 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Clin Favoriten, Vienna, Austria
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1811 / 1811
页数：1
相关论文
共 50 条
  • [41] Tafamidis Free Acid 61 Mg in Patients With Transthyretin Amyloid Cardiomyopathy
    Nativi-Nicolau, Jose
    van der Meer, Peter
    Gundapaneni, Balarama
    Sultan, Marla B.
    Garcia-Pavia, Pablo
    CIRCULATION, 2020, 142
  • [42] Long-term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy
    Damy, T.
    Elliott, P.
    Gundapaneni, B.
    Tai, S. See
    Sultan, M. B.
    Drachman, B. M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2142 - 2142
  • [43] Cardiac imaging in tafamidis-treatment patients with transthyretin amyloid cardiomyopathy
    Rettl, R.
    Mann, C.
    Duca, F.
    Dachs, T. -M.
    Binder, C.
    Kronberger, C.
    Schrutka, L.
    Dalos, D.
    Dona, C.
    Kammerlander, A.
    Beitzke, D.
    Charwat-Resl, S.
    Kastner, J.
    Eslam, R. Badr
    Bonderman, D.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1814 - 1814
  • [44] Tafamidis in Transthyretin Amyloid Cardiomyopathy Effects on Transthyretin Stabilization and Clinical Outcomes
    Maurer, Mathew S.
    Grogan, Donna R.
    Judge, Daniel P.
    Mundayat, Rajiv
    Packman, Jeff
    Lombardo, Ilise
    Quyyumi, Arshed A.
    Aarts, Janske
    Falk, Rodney H.
    CIRCULATION-HEART FAILURE, 2015, 8 (03) : 519 - 526
  • [45] Tafamidis Stabilizes Transthyretin and Improves Clinical Outcomes in Transthyretin Amyloid Cardiomyopathy
    Falk, Rodney
    Maurer, Matthew
    Fedson, Savitri
    Judge, Daniel
    Zeldenrust, Steven
    Quyyumi, Arshed
    Pano, Arian
    Packman, Jeff
    Grogan, Donna
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (08) : S56 - S56
  • [46] Tafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy
    Park, Jonathan
    Egolum, Ugochukwu
    Parker, Shanea
    Andrews, Ebony
    Ombengi, David
    Ling, Hua
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (05) : 470 - 477
  • [47] Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)
    Hanna, Mazen
    Damy, Thibaud
    Grogan, Martha
    Stewart, Michelle
    Gundapaneni, Balarama
    Patterson, Terrell A.
    Schwartz, Jeffrey H.
    Sultan, Marla B.
    Maurer, Mathew S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 141 : 98 - 105
  • [48] Prognostic Role Of Cardiopulmonary Exercise Testing In Wild Type Transthyretin Amyloid Cardiomyopathy Patients Treated With Tafamidis
    Dalia, Tarun
    Acharya, Prakash
    Chan, Wan-Chi
    Sauer, Andrew
    Weidling, Robert
    Fritzlen, John
    Goyal, Amandeep
    Miller, Dana
    Porter, Charles
    Shah, Zubair
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S21 - S21
  • [49] Modeling of Survival and Frequency of Cardiovascular-Related Hospitalization in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis
    Vong, Camille
    Boucher, Martin
    Riley, Steve
    Harnisch, Lutz O.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (05) : 535 - 543
  • [50] Modeling of Survival and Frequency of Cardiovascular-Related Hospitalization in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis
    Camille Vong
    Martin Boucher
    Steve Riley
    Lutz O. Harnisch
    American Journal of Cardiovascular Drugs, 2021, 21 : 535 - 543
12345